Camporedondo, Rejeal-ann M.
HRN: 24-43-23 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/19/2024
CEFUROXIME 1.5GM (VIAL)
05/19/2024
05/20/2024
IV
1.5
Q 8 Hrs X 3 Doses
S/P CS With Intracesarean Section With IUD Under SAB
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes